Australia markets open in 2 hours 8 minutes

Viva Biotech Holdings (VB0.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.0735+0.0085 (+13.08%)
At close: 09:05PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,155,578
2,155,578
2,379,631
2,104,083
696,958
Cost of revenue
1,417,146
1,417,146
1,563,952
1,453,102
392,092
Gross profit
738,432
738,432
815,679
650,981
304,866
Operating expenses
Research development
127,967
127,967
135,835
92,382
66,041
Selling general and administrative
409,656
409,656
404,453
320,285
123,258
Total operating expenses
482,307
482,307
503,818
381,147
179,851
Operating income or loss
256,125
256,125
311,861
269,834
125,015
Interest expense
176,582
176,582
184,674
183,108
62,134
Income before tax
-55,953
-55,953
-459,165
347,701
-356,210
Income tax expense
43,837
43,837
45,055
47,141
22,660
Income from continuing operations
-99,790
-99,790
-504,220
300,560
-378,870
Net income
-116,113
-116,113
-528,475
287,546
-386,880
Net income available to common shareholders
-116,113
-116,113
-528,475
287,546
-386,880
Basic EPS
-0.23
-0.06
-0.28
0.15
-0.25
Diluted EPS
-0.23
-0.14
-0.28
0.08
-0.25
Basic average shares
1,915,437
2,028,679
1,915,437
1,911,530
1,571,507
Diluted average shares
1,915,437
2,074,543
1,915,437
1,970,799
1,571,507